Mexico Peptide Antibiotics Market Size & Outlook, 2025-2030
Related Markets
Mexico peptide antibiotics market highlights
- The Mexico peptide antibiotics market generated a revenue of USD 45.1 million in 2021 and is expected to reach USD 72.8 million by 2030.
- The Mexico market is expected to grow at a CAGR of 5.5% from 2022 to 2030.
- In terms of segment, non-ribosomal synthesized peptide antibiotics was the largest revenue generating product in 2021.
- Non-Ribosomal Synthesized Peptide Antibiotics is the most lucrative product segment registering the fastest growth during the forecast period.
Peptide antibiotics market data book summary
| Market revenue in 2021 | USD 45.1 million |
| Market revenue in 2030 | USD 72.8 million |
| Growth rate | 5.5% (CAGR from 2021 to 2030) |
| Largest segment | Non-ribosomal synthesized peptide antibiotics |
| Fastest growing segment | Non-Ribosomal Synthesized Peptide Antibiotics |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Peptide Antibiotics Market, Non-Ribosomal Synthesized Peptide Antibiotics |
| Key market players worldwide | Pfizer Inc, Merck & Co Inc, AbbVie Inc, GSK PLC, Sandoz Group AG ADR, Novo Holdings, Theravance Biopharma Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.0% of the global peptide antibiotics market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil peptide antibiotics market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 36.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Antibiotics Market Scope
Peptide Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novo Holdings | View profile | 101-250 | Hellerup, Hovedstaden, Denmark, Europe | https://www.novoholdings.dk |
| Sandoz Group AG ADR | View profile | - | - | - |
| Theravance Biopharma Inc | View profile | 99 | Ugland House, South Church Street, George Town, PO Box 309, Grand Cayman, Cayman Islands, KY1-1104 | https://www.theravance.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Mexico peptide antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide antibiotics market will help companies and investors design strategic landscapes.
Non-ribosomal synthesized peptide antibiotics was the largest segment with a revenue share of 72.28% in 2024. Horizon Databook has segmented the Mexico peptide antibiotics market based on peptide antibiotics market, non-ribosomal synthesized peptide antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Mexico peptide antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico peptide antibiotics market databook
-
Our clientele includes a mix of peptide antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico peptide antibiotics market, including forecasts for subscribers. This country databook contains high-level insights into Mexico peptide antibiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico Peptide Antibiotics Market Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
